Product Information
VERAPAMIL SR 180 MG CAPSULE is a generic product labeled by Wilshire Pharmaceuticals Inc., priced at $1.4153 per EA under NDC 52536088201. Its NADAC has been published 81 times since Feb 5, 2025.
FDA first approved this application on May 29, 1990. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
180 mg/1
Manufacturer
Wilshire Pharmaceuticals Inc.NDC
52536088201
Classification
Generic
Dosage Form
CAPSULE, DELAYED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
VERAPAMIL HYDROCHLORIDEApproval Type
Authorized Generic (NDA)
FDA Application
NDA019614FDA Approved
5/29/1990
TE Code
AB
On Market Since
5/29/1990
Pharmacological Classes
Price Statistics
The NADAC for VERAPAMIL SR 180 MG CAPSULE has been published 81 times since Feb 5, 2025, and over the history we have for it it has risen 38.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.4153 per EA |
|---|---|
| All-time high | $2.2961 (Mar 11, 2026) |
| All-time low | $0.9764 (Feb 19, 2025) |
| 52-week high | $2.2961 |
| 52-week low | $1.0263 |
| Median price | $1.1467 |
| Average price | $1.4006 |
| Largest weekly change | +35.2% (Aug 19, 2026) |
| Weeks tracked | 81 |
| Tracking since | Feb 5, 2025 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 26% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of VERAPAMIL SR 180 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for VERAPAMIL SR 180 MG CAPSULE, manufactured by Wilshire Pharmaceuticals Inc., is $1.4153 per EA (NDC 52536088201), effective Aug 19, 2026.
How has the price of VERAPAMIL SR 180 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for VERAPAMIL SR 180 MG CAPSULE has risen 38.6%. It has been tracked across 81 weekly CMS publications since Feb 5, 2025.
What are the highest and lowest recorded NADAC prices for VERAPAMIL SR 180 MG CAPSULE?
Since Feb 5, 2025, the NADAC for VERAPAMIL SR 180 MG CAPSULE has ranged from a low of $0.9764 (Feb 19, 2025) to a high of $2.2961 (Mar 11, 2026), with a median of $1.1467 per EA.
Are there cheaper alternatives to VERAPAMIL SR 180 MG CAPSULE?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, VERAPAMIL SR 180 MG CAPSULE, is $1.0471 per EA — about 26% below VERAPAMIL SR 180 MG CAPSULE.
Who manufactures VERAPAMIL SR 180 MG CAPSULE?
VERAPAMIL SR 180 MG CAPSULE (NDC 52536088201) is labeled by Wilshire Pharmaceuticals Inc., and CMS classifies it as a generic product.